Researchers Develop Genetic Test To Help Identify Patients With Cancer At Highest Risk For Complication From Treatment With Bevacizumab

November 02, 2020

Medscape (10/30, Osterweil, Subscription Publication) reported, “Up to 40% of patients with cancer who are treated with bevacizumab develop severe hypertension and renal toxicity,” but researchers have developed a “genetic test performed before treatment”...
PrevNext
January 2025
SuMoTuWeThFrSa
   1234
567891011
12131415161718
19202122232425
262728293031